Last Updated : February 4, 2013
Details
FilesGeneric Name:
Nebivolol
Project Status:
Complete
Therapeutic Area:
Hypertension
Manufacturer:
Forest Laboratories Canada Inc.
Call for patient/clinician input open:
Brand Name:
Bystolic
Project Line:
Reimbursement Review
Project Number:
SR0307-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Hypertension, essential
Recommendation Type:
Do not list at the submitted price
Final Recommendation:
Files
Last Updated : February 4, 2013